Gilead Sciences (NasdaqGS:GILD) FY Conference Transcript

Gilead Sciences (NasdaqGS:GILD) FY Conference September 09, 2025 10:45 AM ET Company ParticipantsDaniel O’day - Chairman, CEO & DirectorJohanna Mercier - Chief Commercial OfficerConference Call ParticipantsTerence Flynn - Equity Research AnalystTerence FlynnGreat. Thank you everyone for joining us. I'm Terrence Flynn, Morgan Stanley's U.S. biopharma analyst. I'm very pleased to be hosting Gilead Sciences this morning. From the company, we have Daniel O’Day, the company's Chairman and CEO, and Johanna Mercie ...